Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials

scientific article published on 22 February 2015

Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/EJHF.240
P698PubMed publication ID25704364

P50authorFaiez ZannadQ19631268
Stefan D. AnkerQ30310195
Patrick RossignolQ33103963
Nicolas GirerdQ56394664
Luigi TavazziQ64496908
Jay N. CohnQ112435475
P2093author name stringRoberto Latini
Inder S Anand
Gianni Tognoni
Serge Masson
Simona Barlera
Francesco Clemenza
Angelo Castelnovo
GISSI-HF and Val-HeFT Investigators
P2860cites workEffects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trialsQ31096498
The link of unintentional weight loss to cardiac event-free survival in patients with heart failureQ34036472
Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failureQ34093420
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failureQ34106793
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational studyQ34187927
Wasting as independent risk factor for mortality in chronic heart failureQ34421966
The regulation and measurement of plasma volume in heart failureQ34708039
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkersQ35927436
The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysisQ36524299
Cardiac cachexia: a systematic overviewQ37343128
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight lossQ37491629
Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiologyQ38061744
Mechanisms for cachexia in heart failureQ38127358
Impact of obesity and weight loss on cardiac performance and morphology in adultsQ38179545
Obesity and the obesity paradox in heart failureQ38179548
Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradoxQ38188322
Impact of obesity and the obesity paradox on prevalence and prognosis in heart failureQ38195392
Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogramQ38461247
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programmeQ39361054
Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solutionQ40980556
The relationship between obesity and mortality in patients with heart failureQ43723158
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialQ44329632
Increased catabolic activity in adipose tissue of patients with chronic heart failureQ44672396
Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradoxQ44760161
Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic statusQ45150879
Analyzing the weight of evidence on the obesity paradox and heart failure--is there a limit to the madness?Q47219380
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia.Q55067141
Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: A prospective studyQ61793901
Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing EffectsQ61918750
P433issue4
P921main subjectheart failureQ181754
chronic heart failureQ11829287
P304page(s)424-433
P577publication date2015-02-22
P1433published inEuropean Journal of Heart FailureQ5017954
P1476titleLoss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials
P478volume17

Reverse relations

cites work (P2860)
Q87205182Adding insult to injury: heart failure and incident cancer
Q90673843Anabolism to Catabolism: Serologic Clues to Nutritional Status in Heart Failure
Q42668863Association of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis.
Q39752065Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology
Q37594528Cardiac Cachexia: Perspectives for Prevention and Treatment
Q90259014Clinical significance of nutritional status in patients with chronic heart failure-a systematic review
Q91799563Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post-discharge
Q38904288Dietary Self-management in Heart Failure: High Tech or High Touch?
Q38726519Dietary management of heart failure: room for improvement?
Q52560610Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future.
Q36408544Effect of Obesity and Underweight Status on Perioperative Outcomes of Congenital Heart Operations in Children, Adolescents, and Young Adults: An Analysis of Data from the Society of Thoracic Surgeons Database
Q37206834Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration
Q26769905Focus on renal congestion in heart failure
Q89414846Heart failure in the elderly
Q64947391Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial.
Q57797666Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure
Q34681621Muscle wasting and cachexia in heart failure: mechanisms and therapies
Q49183956Muscle wasting and sarcopenia in heart failure and beyond: update 2017.
Q86872516Neuromuscular junction fragmentation and muscle wasting in heart failure: a sharp cut from a Sica sword?
Q92569650Normalizing Plasma Renin Activity in Experimental Dilated Cardiomyopathy: Effects on Edema, Cachexia, and Survival
Q64063186Nutritional Considerations of Cardiovascular Diseases and Treatments
Q58603645Observational Evidence for Unintentional Weight Loss in All-Cause Mortality and Major Cardiovascular Events: A Systematic Review and Meta-Analysis
Q92053510Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-HFpEF Registry
Q39019268Publication trends in cachexia and sarcopenia in elderly heart failure patients
Q50048824Publishing in a heart failure journal-where lies the scientific interest?
Q92462130Renal function, electrolytes, and congestion monitoring in heart failure
Q48511525Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart Failure
Q47311543Sex Differences in Muscle Wasting
Q95837212Spironolactone dose in Heart Failure with Preserved Ejection Fraction: findings from TOPCAT
Q88763819The prognostic impact of malnutrition in patients with severely decompensated acute heart failure, as assessed using the Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score
Q37090681Weight Loss in Obese Patients With Heart Failure.

Search more.